Association between the 21-gene recurrence score (RS) and benefit from adjuvant paclitaxel (Pac) in node-positive (N plus ), ER-positive breast cancer patients (pts): Results from NSABP B-28

被引：4
|
作者：
Mamounas, E. P.
Tang, G.
Paik, S.
Baehner, F. L.
Liu, Q.
Jeong, J-H
Kim, S-R
Butler, S. M.
Jamshidian, F.
Cherbavaz, D. B.
Sing, A. P.
Shak, S.
Julian, T. B.
Lembersky, B. C.
Wickerham, D. L.
Costantino, J. P.
Wolmark, N.
机构：
[1] Natl Surg Adjuvant Breast & Bowel Project, Operat Ctr, Pittsburgh, PA USA
[2] Natl Surg Adjuvant Breast & Bowel Project, Biostat Ctr, Pittsburgh, PA USA
[3] Aultman Hosp, Canton, OH USA
[4] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA
[5] Genom Hlth Inc, Redwood City, CA USA
[6] Allegheny Gen Hosp, Allegheny Canc Ctr, Pittsburgh, PA 15212 USA
[7] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-S1-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S1-10
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic impact of the 21-gene recurrence score (RS) on disease-free and overall survival of node-positive, ER-positive breast cancer patients (pts) treated with adjuvant chemotherapy: Results from NSABP B-28.
    Mamounas, Eleftherios P.
    Tang, Gong
    Paik, Soonmyung
    Baehner, Frederick L.
    Liu, Qing
    Jeong, Jong-Hyeon
    Kim, Seong-Rim
    Butler, Steven M.
    Jamshidian, Farid
    Cherbavaz, Diana B.
    Shak, Steven
    Julian, Thomas B.
    Lembersky, Barry C.
    Wickerham, D. Lawrence
    Costantino, Joseph P.
    Wolmark, Norman
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [2] Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: Results from NSABP B-28
    Mamounas, EP
    Bryant, J
    Leinbersky, B
    Fehrenbacher, L
    Sedlacek, SM
    Fisher, B
    Wickerham, DL
    Yothers, G
    Soran, A
    Wolmark, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3686 - 3696
  • [3] Association between the 21-gene recurrence score assay (RS) and risk of locoregional failure in node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
    Mamounas, E
    Tang, G
    Bryant, J
    Paik, S
    Shak, S
    Costantino, J
    Watson, D
    Wickerham, DL
    Wolmark, N
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S16 - S16
  • [4] The 21-gene Recurrence Score (RS) Predicts Risk of Loco-regional Recurrence (LRR) in Node (+), ER (+) Breast Cancer (BC) after Adjuvant Chemotherapy and Tamoxifen: Results from NSABP B-28
    Mamounas, E. P.
    Tang, G.
    Paik, S.
    Baehner, F. L.
    Liu, Q.
    Jeong, J.
    Kim, S.
    Butler, S. M.
    Jamshidian, F.
    Cherbavaz, D. B.
    Sing, A. P.
    Shak, S.
    Julian, T. B.
    Lembersky, B. C.
    Wickerham, D. L.
    Costantino, J. P.
    Wolmark, N.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S6 - S6
  • [5] 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy
    Mamounas, Eleftherios P.
    Liu, Qing
    Paik, Soonmyung
    Baehner, Frederick L.
    Tang, Gong
    Jeong, Jong-Hyeon
    Kim, S. Rim
    Butler, Steven M.
    Jamshidian, Farid
    Cherbavaz, Diana B.
    Sing, Amy P.
    Shak, Steven
    Julian, Thomas B.
    Lembersky, Barry C.
    Wickerham, D. Lawrence
    Costantino, Joseph P.
    Wolmark, Norman
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (04):
  • [6] Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
    Gong Tang
    Steven Shak
    Soonmyung Paik
    Stewart J. Anderson
    Joseph P. Costantino
    Charles E. Geyer
    Eleftherios P. Mamounas
    D. Lawrence Wickerham
    Norman Wolmark
    Breast Cancer Research and Treatment, 2011, 127 : 133 - 142
  • [7] Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
    Tang, Gong
    Shak, Steven
    Paik, Soonmyung
    Anderson, Stewart J.
    Costantino, Joseph P.
    Geyer, Charles E., Jr.
    Mamounas, Eleftherios P.
    Wickerham, D. Lawrence
    Wolmark, Norman
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 133 - 142
  • [8] Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer
    Woodward, Wendy A.
    Barlow, William E.
    Jagsi, Reshma
    Buchholz, Thomas A.
    Shak, Steven
    Baehner, Frederick
    Whelan, Timothy J.
    Davidson, Nancy E.
    Ingle, James N.
    King, Tari A.
    Ravdin, Peter M.
    Osborne, C. Kent
    Tripathy, Debasish
    Livingston, Robert B.
    Gralow, Julie R.
    Hortobagyi, Gabriel N.
    Hayes, Daniel F.
    Albain, Kathy S.
    JAMA ONCOLOGY, 2020, 6 (04) : 505 - 511
  • [9] 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology
    Mamounas, Eleftherios P.
    Tang, Gong
    Paik, Soonmyung
    Baehner, Frederick L.
    Liu, Qing
    Jeong, Jong-Hyeon
    Kim, S. Rim
    Butler, Steven M.
    Jamshidian, Farid
    Cherbavaz, Diana B.
    Sing, Amy P.
    Shak, Steven
    Julian, Thomas B.
    Lembersky, Barry C.
    Wickerham, D. Lawrence
    Costantino, Joseph P.
    Wolmark, Norman
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 69 - 77
  • [10] 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology
    Eleftherios P. Mamounas
    Gong Tang
    Soonmyung Paik
    Frederick L. Baehner
    Qing Liu
    Jong-Hyeon Jeong
    S. Rim Kim
    Steven M. Butler
    Farid Jamshidian
    Diana B. Cherbavaz
    Amy P. Sing
    Steven Shak
    Thomas B. Julian
    Barry C. Lembersky
    D. Lawrence Wickerham
    Joseph P. Costantino
    Norman Wolmark
    Breast Cancer Research and Treatment, 2018, 168 : 69 - 77
12345